Skylife provides fast and effective neonatal phototherapy treatment that can be administered both in hospitals and at home.
Skylife is the world’s market leader in delivering narrow band of high-intensity phototherapeutic treatment to provide efficient solution for neonatal hyperbilirubinemia. It delivers a narrow band of high-intensity blue light to provide efficient treatment for neonatal hyperbilirubinemia, commonly known as Jaundice. Skylife is designed to be used within most neonatal enclosures, including bassinets, incubators and radiant warmers for babies of all severities of Jaundice. The innovative device is ergonomically designed to empower caregivers with more flexibility to offer different treatment modalities.
Skylife offers the highest spectral power on the market with a tunable setting up to 43,000 units.
Our patented design covers the full length of an infant, from head to toe.
Skylife is the only modern device to provide uniformity across 80% of the treatment area, twice the FDA minimum requirement of only 40%.
Skylife was designed to fit 95 percentile of all infants regardless of age or risk, as well as all enclosures, warmers, and incubators.
With different swaddle consumables available, Skylife can be configured to provide customized care.
Bilicount is a simple disposable point of care strip that measures a unique set of jaundice markers critical in estimating a baby’s hospital stay while providing significantly faster results in less than 2 minutes.
Bilicount measures a unique range of analytes and plots babies' progress over time for easier risk estimation.
Bilicount delivers instantaneous measurements, enabling quicker jaundice diagnoses.
Seamless software integration with HIPAA-compliant hospital patient health information systems